Maximum quantity allowed is 999
请选择数量
CAS RN: 87333-19-5 | 產品號碼: R0219
產品號碼 | R0219 |
純度/分析方法 ![]() |
>98.0%(T)(HPLC) |
分子式 / 分子量 | C__2__3H__3__2N__2O__5 = 416.52 |
外觀與形狀(20°C) | Solid |
儲存條件 ![]() |
Refrigerated (0-10°C) |
應避免的情況 | Heat Sensitive |
包裝和容器 ![]() |
1G-Glass Bottle with Plastic Insert (閲覽圖片) |
CAS RN | 87333-19-5 |
Reaxys-RN | 4214464 |
PubChem Substance ID | 468592790 |
Merck Index(14) | 8103 |
MDL編號 | MFCD00865775 |
產品規格
Appearance | White to Almost white powder to crystal |
Purity(HPLC) | min. 98.0 area% |
Purity(Neutralization titration) | min. 98.0 % |
Melting point | 106.0 to 110.0 °C |
Specific rotation [a]20/D | +35.0 to +41.0 deg(C=1, 0.1N HCl in EtOH) |
性質
熔點 | 109 °C |
比旋光 [α]D | 40° (C=1,0.1 NHCl in EtOH) |
溶解性(可溶於) | Methanol |
GHS
圖形表示 |
![]() |
信號詞 | Danger |
危險性說明 | H360 : May damage fertility or the unborn child. |
防範說明 | P501 : Dispose of contents/ container to an approved waste disposal plant. P202 : Do not handle until all safety precautions have been read and understood. P201 : Obtain special instructions before use. P280 : Wear protective gloves/ protective clothing/ eye protection/ face protection. P308 + P313 : IF exposed or concerned: Get medical advice/ attention. P405 : Store locked up. |
相關法規
RTECS # | GY5879600 |
運輸資料
HS編碼* | 2933.99-000 |
Application
Ramipril: An Angiotensin-Converting Enzyme (ACE) Inhibitor
Ramipril (Hoe 498) is an angiotensin-converting enzyme (ACE) inhibitor. Ramipril is a prodrug which is rapidly hydrolyzed to the active metabolite ramiprilat by hepatic cleavage of the ester group. ACE, a peptidyl dipeptidase, circulates in the plasma and is located on the surface of endothelial cells. ACE is catalyzes the conversion of angiotensin I to the vasoconstrictor substance, angiotensin II. Thereby, ACE inhibitors reduce peripheral vascular resistance and blood pressure. For your reference, we also have a related synthetic intermediate [B5344] of ramipril. (The product is for research purpose only.)
References
- Ramipril. A review of its pharmacological properties and therapeutic efficacy in cardiovascular disorders
- Ramipril: a review of its use in the prevention of cardiovascular outcomes
- Analysis of ACE inhibitors in pharmaceutical dosage forms by derivative UV spectroscopy and liquid chromatography (HPLC)
- A stability-indicating LC method for the simultaneous determination of ramipril and hydrochlorothiazide in dosage forms
- Simultaneous RP-LC determination of losartan potassium, ramipril, and hydrochlorothiazide in pharmaceutical preparations
產品介紹報導
產品文件 (部分產品的分析圖譜無法提供,敬請諒解。)
SDS
請選擇語言。
請求的SDS不可用。
如需更多幫助,請聯繫我們 。
產品規格
檢驗報告(CoA)及其他文檔
請輸入批號
輸入的批號不正確
示例 CoA
可下載CoA示例。注:該示例可能非最新批次的CoA。
目前沒有該產品的 CoA 示例。
分析圖譜
請輸入批號
輸入的批號不正確
很抱歉,您搜索的分析圖譜無法提供。